FDG PET/CT for Staging and Restaging Malignant Mesothelioma

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Malignant mesothelioma is an aggressive cancer of mesothelial cells with a poor prognosis.
• Pleural mesothelioma is more common than peritoneal mesothelioma.
• Histological subtypes (epithelioid, biphasic, sarcomatoid) impact prognosis, with sarcomatoid and biphasic forms being more aggressive.

Purpose of the Study:

• To review the role of [18F]FDG PET/CT in staging and restaging malignant mesothelioma.
• To summarize current literature on imaging modalities for mesothelioma.
• To discuss alternative imaging techniques and future perspectives.

Main Methods:

• Literature review focusing on [18F]FDG PET/CT in malignant mesothelioma.
• Analysis of conventional imaging (contrast-enhanced CT) versus functional/metabolic imaging.
• Inclusion of data on both pleural and peritoneal mesothelioma.

Main Results:

• [18F]FDG PET/CT plays a crucial role in staging and restaging malignant mesothelioma.
• Conventional CT is standard, but functional imaging offers complementary information.
• Specific imaging characteristics of pleural and peritoneal mesothelioma are discussed.

Conclusions:

• [18F]FDG PET/CT is valuable for assessing malignant mesothelioma.
• Further research into advanced imaging techniques is warranted.
• Comprehensive imaging strategies are essential for optimal patient management.